（编辑 李家琪） 证券日报网讯 8月22日晚间，乐普医疗发布公告称，公司于2025年8月21日召开第六届董事会第十六次 会议，审议通过《关于使用募集资金置换预先投入募投项目自筹资金》的议案，同意公司以募集资金置 换预先投入募投项目的自筹资金，置换资金总额为人民币1，686.83万元。 ...

证券日报网讯 8月22日晚间，乐普医疗发布公告称，公司于2025年8月21日召开第六届董事会第十六次 会议和第六届监事会第十一次会议，审议通过了《关于使用部分闲置募集资金暂时补充流动资金》的议 案，同意公司在保证募集资金投资项目资金使用的前提下，使用闲置募集资金不超过人民币40，000万 元用于暂时补充流动资金，使用期限自董事会审议通过之日起不超过12个月，到期归还至募集资金专用 账户。 （编辑 李家琪） ...

（文章来源：证券日报） 证券日报网讯 8月22日晚间，鱼跃医疗发布公告称，2025年半年度公司实现营业收入4，658，967， 431.03元，同比增长8.16%；归属于上市公司股东的净利润为1，202，704，408.78元，同比增长 7.37%。 ...

证券日报网讯 8月22日晚间，欧普康视发布公告称，公司第四届董事会第十八次会议审议通过了《欧普 康视科技股份有限公司2025年半年度报告及摘要》等多项议案。 （文章来源：证券日报） ...

Group 1 - The core point of the article is that Yuyue Medical announced the approval of multiple proposals during the fifth meeting of its sixth board of directors held on August 22 [2]

Group 1 - The company, Lepu Medical, announced on August 22 that it will hold the 16th meeting of the 6th Board of Directors and the 11th meeting of the 6th Supervisory Board on August 21, 2025, to review the proposal for applying to register and issue medium-term notes [2] - The company aims to improve financing efficiency and rationally utilize different financing channels to reduce financing costs [2] - The company plans to apply for registration with the China Interbank Market Dealers Association and intends to publicly issue medium-term notes not exceeding RMB 1 billion (including 1 billion) in the national interbank bond market [2]

（文章来源：证券日报） 证券日报网讯 8月22日晚间，欧普康视发布公告称，公司第四届监事会第十八次会议审议通过了《关于 2025年半年度利润分配预案的议案》等多项议案。 ...

Core Viewpoint - Kailing Medical's stock price decreased by 3.20% to 34.51 yuan as of August 22, 2025, with a trading volume of 291 million yuan and a fluctuation of 3.70% [1] Company Performance - Kailing Medical reported a revenue of 964 million yuan and a net profit of 47.03 million yuan for the first half of 2025 [1] - The net profit for the second quarter increased by 382.45% compared to the previous quarter [1] - The company invested 244 million yuan in research and development, accounting for 25.31% of its revenue [1] Business Segments - The minimally invasive surgery business and soft endoscope products have emerged as the second growth curve for the company [1] Market Activity - On the same day, Kailing Medical experienced a net outflow of 19.55 million yuan in main funds, with a cumulative net outflow of 39.58 million yuan over the past five days [2]

Core Insights - Yuyue Medical's stock price on August 22 was 36.60 yuan, down 0.25% from the previous trading day, with a trading volume of 4.17 billion yuan [1] - The company reported a 2025 semi-annual revenue of 4.659 billion yuan, an increase of 8.16% year-on-year, and a net profit attributable to shareholders of 1.203 billion yuan, up 7.37% year-on-year [1] - The company announced a mid-term dividend plan, proposing a cash dividend of 2 yuan for every 10 shares [1] Business Performance - The blood glucose management and POCT solutions segment experienced significant growth, with revenue increasing by 20% year-on-year [1] - The emergency solutions and other segments saw a revenue increase of 30.54% year-on-year [1] Capital Flow - On August 22, Yuyue Medical experienced a net outflow of 15.1716 million yuan in main funds, while the net inflow over the past five days was 1.24 billion yuan [1]

（编辑 任世碧） 证券日报网讯 8月22日晚间，欧普康视发布关于2025年半年度利润分配预案的公告称，公司拟向全体股 东每10股派发现金红利人民币0.56元（含税），合计派发现金红利50，184，533.62元。 ...